Holger Knoth

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

Uwe Platzbecker, Martin Wermke, J. Radke et al. · Leukemia · 2011 · 395 citations · Full text

Medicine, Hematology, Pharmacology +17

One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent <i>Helicobacter pylori</i> Resistant to Both Metronidazole and Clarithromycin

Stephan Miehlke, Wulf Schneider‐Brachert, Christian Kirsch et al. · Helicobacter · 2008 · 68 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

Stephan Miehlke, Susanne Krasz, Wulf Schneider‐Brachert et al. · Helicobacter · 2011 · 57 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery

Jörg Lützner, Lars Donath, Luise Tittl et al. · Thrombosis and Haemostasis · 2012 · 52 citations

Medicine, Orthopaedic Surgery, Surgery +17

Hospital use of systemic antifungal drugs

Katja de With, Michaela Steib–Bauert, Holger Knoth et al. · BMC Clinical Pharmacology · 2005 · 45 citations · Full text

Pharmacy, Hospital Pharmacy, Antimicrobial Pharmacotherapy +15